title: Do human lymphocytes exposed to the fallout of the Chernobyl accident exhibit an adaptive response? 1. Challenge with ionizing radiation.
abstract: Several studies suggest that cells appear to become less susceptible to the induction of radiation damage, and in particular of chromosome and chromatid aberrations in short-term cultures of human lymphocytes, when a challenge exposure to ionizing radiation is preceded by a low 'adaptive' dose. Contradictory results have been reported on the conditions under which the phenomenon can be evidenced. In the present work, circulating lymphocytes of 13 children contaminated from the fallout after the Chernobyl accident were tested for their capability to exhibit an adaptive response in experiments in which the challenge dose was administered to stimulated lymphocytes in the S-G2 phase. Furthermore, the possible influence of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) polymerase, was also investigated. Our results indicate that, at least in the instance of the end-point here used (chromosome and chromatid aberrations, the former resulting possibly from the Cs burden), human lymphocytes, chronically exposed to low doses from fallout, do not exhibit any decreased susceptibility to ionizing radiation. However, as reported in the accompanying paper, the same samples appear to show an 'adaptive' response when exposed to a challenge treatment with bleomycin (B. Tedeschi et al., 1995, this issue).
authors.affiliation: Environmental Department, ENEA Casaccia, Rome, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Padovani
authors.forename: M
authors.initials: M
authors.lastname: Appolloni
authors.forename: P
authors.initials: P
authors.lastname: Anzidei
authors.forename: B
authors.initials: B
authors.lastname: Tedeschi
authors.forename: D
authors.initials: D
authors.lastname: Caporossi
authors.forename: P
authors.initials: P
authors.lastname: Vernole
authors.forename: F
authors.initials: F
authors.lastname: Mauro
mesh_terms: D000222:Adaptation, Physiological; D001549:Benzamides / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects / Q000528:radiation effects; D002478:Cells, Cultured; D002648:Child; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000528:radiation effects* / Q000648:ultrastructure; D008297:Male; D011829:Radiation Dosage; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D018788:Radioactive Hazard Release; D012854:Sister Chromatid Exchange / Q000187:drug effects / Q000528:radiation effects*; D014455:Ukraine
chemical_list: D001549:Benzamides; D011838:Radiation-Sensitizing Agents; C025160:3-aminobenzamide